Evidence map›Paper›PMID 34724982›Full record

ArticleBMC rheumatology2021

Epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the Zoroastrian population in Yazd, Iran: a WHO-ILAR COPCORD study (stage 1).

Ali Dehghan, Hossein Soleimani Salehabadi, Ahmadreza Jamshidi, Zohre Kamali, Mojgan Mali, Seyedeh Tahereh Faezi, Azarakhsh Baghdadi, Sogol Alesaeidi, Fatemeh Sahraei, Niloufar Azizi and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Epidemiology and treatment of Adamantiades-Behçet's disease in Germany: A healthcare claims database study.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Ali DehghanDepartment of Internal Medicine, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Hossein Soleimani SalehabadiDepartment of Internal Medicine, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Ahmadreza JamshidiRheumatology Research Center, Tehran University of Medical Sciences, North Amirabad Street, Tehran, 1411713137, Iran.
Zohre KamaliDiabetic Care Center, Shahid Sadoughi University, Yazd, Iran.
Mojgan MaliZiayee Hospital, Shahid Sadoughi University, Ardakan, Yazd, Iran.
Seyedeh Tahereh FaeziRheumatology Research Center, Tehran University of Medical Sciences, North Amirabad Street, Tehran, 1411713137, Iran. tfaezi@sina.tums.ac.ir.
Azarakhsh BaghdadiRheumatology Research Center, Tehran University of Medical Sciences, North Amirabad Street, Tehran, 1411713137, Iran. azarakhsh.baghdadi88@gmail.com.ORCID http://orcid.org/0000-0003-0783-9207
Sogol AlesaeidiShahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Fatemeh SahraeiShahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Niloufar AziziFeiz Hospital, Isfahan, Iran.
Sanaz ZandShahid Sadoughi University of Medical Sciences, Yazd, Iran.
Sara Sadat YasiniShahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Maryam NamaziFeiz Hospital, Isfahan, Iran.
Atefe DayaShahid Sadoughi University of Medical Sciences, Yazd, Iran.
Ryan NazemianClinical Translational Science PhD Program, Case Western Reserve University, Cleveland, OH, USA.
Farimah ShamsiShahid Sadoughi University of Medical Sciences, Yazd, Iran.
Mohammad NejadhosseinianRheumatology Research Center, Tehran University of Medical Sciences, North Amirabad Street, Tehran, 1411713137, Iran.
Fereydoun DavatchiRheumatology Research Center, Tehran University of Medical Sciences, North Amirabad Street, Tehran, 1411713137, Iran.
Shahid Sadoughi University of Medical Sciences and Health Services · IRTehran University of Medical Sciences · IRHafez Hospital · IRCase Western Reserve University · US

Funding

Shahid Sadoughi University of Medical Sciences 3036
6 · The paper itself

Abstract

backgroundThe purpose of this study was to determine the prevalence of musculoskeletal complaints, rheumatologic diseases, and disability among the Zoroastrian population in Iran.

methodsThe city of Yazd, in central Iran was selected for this study, with the highest population of Zoroastrians in Iran. Subjects were selected by cluster sampling of 9 neighborhoods populated with Zoroastrians. Subjects ≥15 years old were interviewed by trained interviewers in their houses. The validated Farsi translation of Community Oriented Program for the Control of Rheumatic Disease (COPCORD) Core Questionnaire (CCQ) was used for this study. Subjects with musculoskeletal complaints (pain, stiffness and/or swelling) were examined by a rheumatologist. Laboratory tests and radiographic exams were performed when deemed necessary.

resultsTwo-thousand subjects were interviewed during a 12-month period, of which 956 were male, and 1044 were female. The mean age was 41.1 ± 18.3 years (95%CI: 40.3-41.9). 36.9% of the subjects had university-level education. In the 7 days prior to the interview, 27.6% of the subjects had musculoskeletal complaints, with the knee, dorsolumbar spine, and shoulder being the most common sites of complaints. The most common rheumatologic diagnoses were osteoarthritis (21.5%) and low back pain (10.3%). Rheumatoid arthritis was diagnosed in 1.2% of the subjects.

conclusionsThe epidemiology of musculoskeletal complaints and rheumatologic disorders was inconsistent with previous COPCORD studies in Iran, with a lower prevalence of musculoskeletal complaints in general, lower rates of Behçet and lupus, and a higher prevalence of rheumatoid arthritis. The findings of this study can be for development of better prevention, screening, and treatment programs for the vulnerable population of Zoroastrians in Iran.

Indexed as

Community-based epidemiologyCOPCORDDisabilityMusculoskeletal disordersRheumatic diseasesZoroastrians

Identifiers

PMID34724982
PMCPMC8561944
OpenAlexW3208704893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.